Maravai LifeSciences Faces Securities Fraud Allegations

San Diego, Tuesday, 29 April 2025.
Investors sue Maravai LifeSciences over claims of misleading financial information, citing internal control issues that led to a $3.9 million revenue misstatement and a significant stock price drop.